Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser
NCT ID: NCT06996353
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2025-05-26
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Vision Disturbances Due to Corneal Irregularities by Trans-epithelial Optical Phototherapeutic Keratectomy (TE-oPTK)
NCT03841253
A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children
NCT06305663
Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment
NCT04698174
Effects on Ocular Parameters of Myopic Eyes After Orthokeratology in Myopic Children
NCT03516357
Peripheral Optics in Myopia and Orthokeratology
NCT00978679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The EpiMaster application software is not used in this clinical investigation, consequently, it is a merely observational investigation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PTK-PRK refractive treatment
The PTK-PRK refractive treatment will be done according to routine clinical practice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient will be able to understand the patient information and willing to sign an informed consent
* Patient will be willing to comply with all follow-up visits and the respective examinations
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optana GmbH
OTHER
London Vision Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Z Reinstein, MD
Role: STUDY_DIRECTOR
London Vision Clinic Ltd., London, United Kingdom
Sheetal Brar, MD
Role: PRINCIPAL_INVESTIGATOR
Pro Sight Eye Hospital, Chandigarh, India
Aadithreya Varman, MD
Role: PRINCIPAL_INVESTIGATOR
Uma Eye Clinic, Chennai, India
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pro Sight Eye Hospital
Chandigarh, Punjab Haryana, India
Uma Eye Clinic
Chennai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LoVC-011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.